Cargando…
The future of retinal gene therapy: evolving from subretinal to intravitreal vector delivery
Inherited retinal degenerations are a leading and untreatbale cause of blindness, and as such they are targets for gene therapy. Numerous gene therapy treatments have progressed from laboratory research to clinical trails, and a pioneering gene therapy received the first ever FDA approval for treati...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328774/ https://www.ncbi.nlm.nih.gov/pubmed/33510064 http://dx.doi.org/10.4103/1673-5374.306063 |